USFDA pulls up Sun Pharma over lack of cleanliness
New Delhi, July 3 Sun Pharma failed to adequately clean and maintain equipment used for drug manufacturing at its Dadra-based manufacturing plant, as per the US Food and Drug Administration (USFDA). In a warning letter issued to company’s MD Dilip...
Advertisement
New Delhi, July 3
Sun Pharma failed to adequately clean and maintain equipment used for drug manufacturing at its Dadra-based manufacturing plant, as per the US Food and Drug Administration (USFDA).
In a warning letter issued to company’s MD Dilip Shanghvi on June 18, the US health regulator stated it inspected the plant in Dadra and Nagar Haveli and Daman and Diu in December, 2023.
Advertisement
“Your firm failed to clean, maintain, and, as appropriate for the nature of the drug…,” the USFDA said.
Advertisement
×
Unlock Exclusive Insights with The Tribune Premium
Take your experience further with Premium access.
Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly
Monthly
Already a Member? Sign In Now
Advertisement
Advertisement
Advertisement